SVP, CFO of BioMarin Pharmaceutical Inc. (BMRN) Jeffrey H Cooper sells 11,250 shares of BMRN on 11/24/2010 at an average price of $27.5 a share.

Biomarin Pharmaceutical Inc. has a market cap of $2.73 billion; its shares were traded at around $26.72 with a P/E ratio of 1336 and P/S ratio of 8.4.

BMRN is in the portfolios of Richard Aster Jr of Meridian Fund, Columbia Wanger of Columbia Wanger Asset Management, PRIMECAP Management, Stanley Druckenmiller of Duquesne Capital Management, LLC, RS Investment Management, Pioneer Investments, Bruce Kovner of Caxton Associates, Steven Cohen of SAC Capital Advisors, Chuck Royce of Royce& Associates.

This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.

CEO Recent Trades:

• Sell: CEO Jean Jacques Bienaime sold 1,000 shares of BMRN stock on 11/23/2010 at the average price of 27.02. Jean Jacques Bienaime owns at least 93,567 shares after this. The price of the stock has decreased by 1.11% since.


• Sell: CEO Jean Jacques Bienaime sold 1,000 shares of BMRN stock on 11/18/2010 at the average price of 25.99. Jean Jacques Bienaime owns at least 93,567 shares after this. The price of the stock has increased by 2.81% since.


• Sell: CEO Jean Jacques Bienaime sold 2,000 shares of BMRN stock on 11/08/2010 at the average price of 25.78. Jean Jacques Bienaime owns at least 93,567 shares after this. The price of the stock has increased by 3.65% since.


• Sell: CEO Jean Jacques Bienaime sold 7,500 shares of BMRN stock on 11/03/2010 at the average price of 25.54. Jean Jacques Bienaime owns at least 93,567 shares after this. The price of the stock has increased by 4.62% since.


• Sell: CEO Jean Jacques Bienaime sold 1,000 shares of BMRN stock on 09/08/2010 at the average price of 22.22. Jean Jacques Bienaime owns at least 95,067 shares after this. The price of the stock has increased by 20.25% since.

CFO Recent Trades:

• Sell: SVP, CFO Jeffrey H Cooper sold 28,750 shares of BMRN stock on 10/29/2010 at the average price of 25.32. Jeffrey H Cooper owns at least 26,486 shares after this. The price of the stock has increased by 5.53% since.


• Sell: SVP, CFO Jeffrey H Cooper sold 15,209 shares of BMRN stock on 10/25/2010 at the average price of 24. Jeffrey H Cooper owns at least 26,486 shares after this. The price of the stock has increased by 11.33% since.


• Sell: SVP, CFO Jeffrey H Cooper sold 6,000 shares of BMRN stock on 09/13/2010 at the average price of 22.85. Jeffrey H Cooper owns at least 26,486 shares after this. The price of the stock has increased by 16.94% since.

This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.

Directors and Officers Recent Trades:

• Sell: VP, Human Resources Mark Wood sold 2,479 shares of BMRN stock on 11/22/2010 at the average price of 26.6. Mark Wood owns at least 14,243 shares after this. The price of the stock has increased by 0.45% since.


• Sell: EVP, Chief Business Officer Steve Aselage sold 39,875 shares of BMRN stock on 11/18/2010 at the average price of 25.84. Steve Aselage owns at least 29,881 shares after this. The price of the stock has increased by 3.41% since.


• Sell: SVP, General Counsel George Eric Davis sold 10,371 shares of BMRN stock on 11/04/2010 at the average price of 25.83. George Eric Davis owns at least 27,901 shares after this. The price of the stock has increased by 3.45% since.


• Sell: SVP, General Counsel George Eric Davis sold 10,371 shares of BMRN stock on 11/04/2010 at the average price of 25.83. George Eric Davis owns at least 27,901 shares after this. The price of the stock has increased by 3.45% since.


• Sell: EVP, Technical Operations Robert Baffi sold 2,000 shares of BMRN stock on 11/03/2010 at the average price of 25.24. Robert Baffi owns at least 67,713 shares after this. The price of the stock has increased by 5.86% since.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool